Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation

MLA

Vincenzo Tombolini, et al. “Biological Rationale for the Use of DNA Methyltransferase Inhibitors as New Strategy for Modulation of Tumor Response to Chemotherapy and Radiation.” Molecular Cancer, vol. 9, no. 1, Nov. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2af91aac8687a522533d8a2aa63951a2&authtype=sso&custid=ns315887.

APA

Vincenzo Tombolini, Bianca M. Zani, Claudio Festuccia, Richard G. Pestell, Vladimir M. Popov, Francesco Marampon, & Giovanni Luca Gravina. (2010). Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation. Molecular Cancer, 9(1).

Chicago

Vincenzo Tombolini, Bianca M. Zani, Claudio Festuccia, Richard G. Pestell, Vladimir M. Popov, Francesco Marampon, and Giovanni Luca Gravina. 2010. “Biological Rationale for the Use of DNA Methyltransferase Inhibitors as New Strategy for Modulation of Tumor Response to Chemotherapy and Radiation.” Molecular Cancer 9 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2af91aac8687a522533d8a2aa63951a2&authtype=sso&custid=ns315887.